Infinity Pharmaceuticals, Inc. (INFI) Misses Q1 EPS by 3c
Tweet Send to a FriendGet Alerts INFI Hot Sheet
Trade INFI Now!
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported Q1 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $25.2 million versus the consensus estimate of $26.18 million.
For earnings history and earnings-related data on Infinity Pharmaceuticals, Inc. (INFI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Infinity Pharmaceuticals, Inc. (INFI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- L Brands, Inc. (LTD) Tops Q1 EPS by 2c; Guides Q2, FY13 EPS
- Compuware Corp (CPWR) Reports In-Line Q4 EPS; Guides FY14 EPS, Revs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
